Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

4basebio Plc (4BB) Share Price

Price 712.50p on 18-11-2025 at 06:00:01
Change 0.00p 0%
Buy 0.00p
Sell 0.00p
Last Trade: Sell 3.00 at 700.25p
Day's Volume: 0
Last Close: 712.50p
Open: 0.00p
ISIN: GB00BMCLYF79
Day's Range 0.00p - 0.00p
52wk Range: 710.00p - 1,300.00p
Market Capitalisation: £110.33m
VWAP: 0.00p
Shares in Issue: 15.48m

4basebio Plc (4BB) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 3 700.25p Ordinary
16:07:45 - 14-Nov-25
Unknown* 2,250 725.00p Negotiated Trade
08:00:15 - 14-Nov-25
Unknown* 1,100 720.00p Ordinary
08:00:15 - 13-Nov-25
Unknown* 1,400 710.80p Ordinary
15:17:47 - 12-Nov-25
Unknown* 1,400 712.00p Ordinary
15:17:18 - 12-Nov-25
Unknown* 6,575 675.00p Negotiated Trade
11:03:08 - 12-Nov-25
Unknown* 0 700.00p SI Trade
10:53:55 - 12-Nov-25
Unknown* 0 700.00p SI Trade
10:53:55 - 12-Nov-25
Unknown* 1,500 720.00p Ordinary
10:53:11 - 12-Nov-25
Sell* 1 710.15p Ordinary
09:00:33 - 12-Nov-25
See more 4basebio Plc trades

4basebio Plc (4BB) Share Price History

Time period:
to
Date Open High Low Close Volume
18th Nov 2025 (Tue) 712.50 712.50 712.50 712.50 0
17th Nov 2025 (Mon) 712.50 712.50 712.50 712.50 0
14th Nov 2025 (Fri) 712.50 712.50 712.50 712.50 2,253
13th Nov 2025 (Thu) 712.50 712.50 712.50 712.50 1,100
12th Nov 2025 (Wed) 717.50 712.50 710.00 712.50 4,441
11th Nov 2025 (Tue) 785.00 785.00 720.00 720.00 3,684
10th Nov 2025 (Mon) 785.00 820.00 785.00 785.00 19
7th Nov 2025 (Fri) 785.00 820.00 750.00 785.00 151
6th Nov 2025 (Thu) 785.00 785.00 785.00 785.00 300
5th Nov 2025 (Wed) 785.00 785.00 785.00 785.00 19
4th Nov 2025 (Tue) 785.00 785.00 785.00 785.00 0
3rd Nov 2025 (Mon) 790.00 790.00 785.00 785.00 2,225
31st Oct 2025 (Fri) 790.00 790.00 790.00 790.00 1
30th Oct 2025 (Thu) 785.00 790.00 785.00 790.00 771
29th Oct 2025 (Wed) 785.00 785.00 785.00 785.00 505
28th Oct 2025 (Tue) 785.00 785.00 785.00 785.00 1,876
27th Oct 2025 (Mon) 725.00 785.00 725.00 785.00 5,568
24th Oct 2025 (Fri) 725.00 725.00 725.00 725.00 13
23rd Oct 2025 (Thu) 725.00 725.00 725.00 725.00 5,934
22nd Oct 2025 (Wed) 725.00 725.00 725.00 725.00 1
21st Oct 2025 (Tue) 725.00 725.00 725.00 725.00 216
20th Oct 2025 (Mon) 760.00 760.00 725.00 725.00 527
See more 4basebio Plc price history

4basebio Plc (4BB) Regulatory News

Date Source Headline
27th Oct 2025 7:00 am PRN Synthetic opDNA® utilised in Phase I/II US clinical trials
10th Oct 2025 11:30 am PRN Result of Extraordinary General Meeting
30th Sep 2025 4:20 pm PRN Director Dealing
29th Sep 2025 7:00 am PRN Half-year Report
22nd Jul 2025 7:00 am PRN Employee Long Term Incentive Plan and Issue of Equity
8th Jul 2025 10:30 am PRN Director Appointment, Board Change
3rd Jul 2025 7:00 am PRN Holding(s) in Company
3rd Jul 2025 7:00 am PRN Holding(s) in Company
2nd Jul 2025 7:00 am PRN Holding(s) in Company
2nd Jul 2025 7:00 am PRN Holding(s) in Company
See more 4basebio Plc regulatory news

4basebio Plc (4BB) Share News

4basebio says "tier one" partner tests vaccine from its template

27th Oct 2025 12:40

(Alliance News) - 4basebio PLC on Monday said its synthetic DNA product has been used in US clinical trials by a "global tier one" pharmaceutical partner. Read More

EARNINGS: Next 15 profit falls; 4basebio and Mollyroe losses widen

1st Oct 2025 12:57

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and Tuesday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

20th Jun 2025 12:02

Read More

4basebio expects to sustain DNA sales growth momentum in 2025

27th May 2025 11:57

(Alliance News) - 4basebio on Tuesday reported a wider pretax loss in 2024, despite higher revenue, and said it is optimistic about the year to come. Read More

IN BRIEF: 4basebio hits "critical milestone" as it secures GMP licence

2nd Apr 2025 09:51

4basebio PLC - Cambridge, England-based life sciences company and manufacturer of synthetic DNA products - Secures good manufacturing practice, or GMP, certification for its UK DNA manufacturing facility from the UK Medicines & Healthcare Products Regulatory Agency. This authorises it to manufacture and supply investigational medicinal product drug substance and critical starting biological medicinal materials used in advanced therapy medicinal products from its Cambridge facility, says the firm. Adds that the certification strengthens its position in the advanced therapeutics field and progresses it towards commercialisation and patient care for a range of advanced therapies. Chief Executive Heikki Lanckriet says: "Achieving GMP certification is a critical milestone for 4basebio, validates our ability to supply synthetic DNA for clinical applications and underscores the hard work and innovation of our team and sets the stage for the next phase of growth for the company." Read More

See more 4basebio Plc news
FTSE 100 Latest
Value9,675.43
Change0.00

Login to your account

Forgot Password?

Not Registered